 | • レポートコード：B-MOR-040968 • 出版社/出版日：Mordor Intelligence / 2018年2月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：食品・飲料 |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、アスコルビン酸の世界市場について調べ、アスコルビン酸の世界規模、市場動向、市場環境、エンドユーザー別（医薬、食品・飲料、パーソナルケア、その他）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・アスコルビン酸の世界市場インサイト ・アスコルビン酸の世界市場環境 ・アスコルビン酸の世界市場動向 ・アスコルビン酸の世界市場規模 ・アスコルビン酸の世界市場規模：エンドユーザー別（医薬、食品・飲料、パーソナルケア、その他） ・アスコルビン酸の世界市場：地域別市場規模・分析 ・アスコルビン酸の北米市場規模・予測 ・アスコルビン酸のアメリカ市場規模・予測 ・アスコルビン酸のヨーロッパ市場規模・予測 ・アスコルビン酸のアジア市場規模・予測 ・関連企業情報・競争状況 |
The market accounted for USD 860.8 million in 2016 and is expected to reach USD 1103.15 million by 2023, registering a CAGR of 5.1% during the forecast period of 2018-2023.
Ascorbic acid, with its salt derivatives, and ascorbyl palmitate is classified as food additives by the European Community and registered as ‘Generally Recognized as Safe’ (GRAS) substance by the US Food & Drug Administration (FDA), which has accelerated the demand for ascorbic acid from food & beverages industry in the European region.
Increasing vitamin deficiencies
The global ascorbic acid market is expected to witness a high growth rate in the coming decade, owing to vitamin deficiency concerns caused due to changing lifestyles and dietary habits, around the world. Asia-Pacific is expected to be the fastest growing market for ascorbic acid, during the forecast period, due to the growing demand and the availability of low-cost manufacturing facilities in China. The North American and European markets are set to grow due to the rising health issues like diabetes which in turn is fueling the demand for ascorbic acid as a substitute for low-calorie sweetener.
Asia-Pacific holds the largest market share
Ascorbic acid, a common source of vitamin C, is used in various important end-use industries. The market is segmented based on end-user, into pharmaceuticals, food & beverages, personal care and others. Ascorbic acid finds a major application in the pharmaceutical industry with the manufacture of antioxidants. The food & beverage industry holds a major share and is growing at a high rate, owing to the rising health issues, thus, acting as a substitute for sweeteners. Asia-Pacific holds the largest market share.
Major Players: DSM, NORTHEAST PHARMACEUTICAL GROUP, SPEC-CHEM, SHANDONG LUWEI PHARMACEUTICA, TOPSCIENCE, BACTOLAC PHARMACEUTICAL Inc., LUCKERKONG BIOTECH, ALAND NUTRACEUTICALS GROUP, KING-PHARM, CHENGXIN PHARMA, FRESHINE
Reasons to Purchase this Report
• Analyzing outlook of the market with the recent trends and Porter’s five forces analysis
• Market dynamics which essentially consider the factors which are impelling the present market scenario along with growth opportunities of the market in the years to come
• Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
• Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market
• Competitive landscape involving the market share of major players along with the key strategies adopted for development in the past five years
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis and strategies employed by the major market players
• 3 months analyst support along with the Market Estimate sheet in excel.
Customization of the Report
• Value chain analysis
• Consumer behavior analysis in country level
1. INTRODUCTION
1.1 Key Deliverables of the Study
1.2 Study Assumptions
1.3 Market Definition
2. RESEARCH APPROACH & METHODOLOGY
2.1 Introduction
2.2 Study Timeline
2.3 Study Phases
2.3.1 Secondary Research
2.3.2 Statistical Analysis
2.3.3 Expert Validation
3. KEY FINDINGS
4. MARKET DYNAMICS
4.1 Drivers
4.1.1 Increasing Demand for Food and Health Supplements
4.1.2 Technological Advancements in Various Application Industries
4.2 Restraints
4.2.1 Fluctuation in raw material prices
4.2.2 Wide availability of immediate substitute
4.3 Opportunities
4.3.1 Potential demand in the Asia-Pacific market
4.3.2 Growing investment in R&D by major companies
4.4 Porter’s Five Force Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products & Services
4.4.5 Degree of Competition
5. MARKET SEGMENTATION
5.1 By End-User
5.1.1 Pharmaceutical
5.1.2 Food & Beverages
5.1.3 Personal care
5.1.4 Others
5.2 By Geography
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Africa
6. COMPETITIVE LANDSCAPE
6.1 Strategy adopted by Key players
6.2 Most active companies in the past five years
6.3 Market Share Analysis
7. COMPANY PROFILES
7.1 DSM
7.1.1 Overview
7.1.2 Financials
7.1.3 Product types
7.1.4 Strategies
7.2 Northeast Pharmaceutical Group
7.2.1 Overview
7.2.2 Financials
7.2.3 Product types
7.2.4 Strategies
7.3 Shandong Luwei Pharmaceutical
7.3.1 Overview
7.3.2 Financials
7.3.3 Product types
7.3.4 Strategies
7.4 Bactolac Pharmaceutical Inc
7.4.1 Overview
7.4.2 Financials
7.4.3 Product types
7.4.4 Strategies
7.5 Aland Nutraceuticals Group
7.5.1 Overview
7.5.2 Financials
7.5.3 Product types
7.5.4 Strategies
7.6 DuPont
7.6.1 Overview
7.6.2 Financials
7.6.3 Product types
7.6.4 Strategies
7.7 FreShine
7.7.1 Overview
7.7.2 Financials
7.7.3 Product types
7.7.4 Strategies
7.8 Luckerkong Biotech
7.8.1 Overview
7.8.2 Financials
7.8.3 Product types
7.8.4 Strategies
7.9 King-pharm
7.9.1 Overview
7.9.2 Financials
7.9.3 Product types
7.9.4 Strategies
7.10 Top science
7.10.1 Overview
7.10.2 Financials
7.10.3 Product types
7.10.4 Strategies
7.11 BASF
7.11.1 Overview
7.11.2 Financials
7.11.3 Product types
7.11.4 Strategies
7.12 Dishman Group
7.12.1 Overview
7.12.2 Financials
7.12.3 Product types
7.12.4 Strategies
7.13 GlaxoSmithKline Plc
7.13.1 Overview
7.13.2 Financials
7.13.3 Product types
7.13.4 Strategies
7.14 CSPC Pharmaceutical Group
7.14.1 Overview
7.14.2 Financials
7.14.3 Product types
7.14.4 Strategies
8. APPENDIX
8.1 Disclaimer
8.2 Sources
8.3 Sources